World News – GB – Cholesterol-lowering drugs linked to reduced cancer-related deaths in women


We have updated our privacy policy to clarify how we use your personal data

News Oct 212020
| Wiley Original Story

Among women with breast cancer, colorectal cancer or melanoma, those who took cholesterol-lowering drugs were less likely to die from cancer, according to an analysis published in the British Journal of Clinical Pharmacology The analysis included 20,046, 11,719, and 6,430 women in Australia diagnosed with breast cancer, colorectal cancer and melanoma, respectively, from 2003 to 2013 The women had received cholesterol-lowering drugs such as statins prior to their diagnosis The more women took these drugs consistently within a year of being diagnosed with cancer, the lower their risk of dying from the disease, suggesting that the drugs may have anti-tumor effects »If this reverse adherence-response relationship is confirmed, cholesterol lowering drugs – primarily statins – could be reused as adjuvant therapy to improve cancer prognosis, » said co-author Jia-Li Feng, BMed, MMed, PhD, by QIMR Berghofer Medical Research Institute Reference: Feng JL, Qin X Does Adherence to Lipid-Lowering Drugs Improve Cancer Survival? A National Study in Breast and Colorectal Cancer and Melanoma Br J Clin Pharmacol 2020doi: 101111 / bcp14573 This article has been republished from the following materials Note: Material may have been modified for length and content For more information, please contact the cited source

Anti-inflammatory drug reduces disease progression in preclinical model of MS

Intranasal administration of an anti-inflammatory drug helped reduce disease progression in a preclinical model of multiple sclerosis, according to a recent study from the University of Alberta

Biomarker That Appears Before Stomach Cancer Development May Help Early Detection

A promising new biomarker that appears in patients before stomach cancer develops may help early detection of disease and improve patient response to treatment, researcher study results show in Health Sciences from the University of Arizona

Potential global reluctance to accept a COVID-19 vaccine

A research team from the City University of New York Graduate School of Public Health and Health Policy (CUNY SPH), the Barcelona Institute for Global Health (ISGlobal), the Vaccine Confidence Project of the London School of Hygiene and Tropical Medicine (LSHTM) and Georgetown University Law School announced today that Nature Medicine has published their research revealing potential global reluctance to accept a COVID-19 vaccine

Do you like what you just read? You can find similar content on the communities below

To personalize the content you see on the Technology Networks home page, log in or subscribe for free

Online seminar

Cholesterol, colorectal cancer, statin, QIMR Berghofer Institute for Medical Research

World news – GB – Cholesterol lowering drugs linked to reduction in cancer-related deaths in women



Donnez votre point de vue et aboonez-vous!



Votre point de vue compte, donnez votre avis

[maxbutton id= »1″]